Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasquale Roberge

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
The Psychiatric Clinics of North America|October 30, 2017
Transdiagnostic TherapyPeter J Norton, Pasquale Roberge
Journal of the Neurological Sciences|January 21, 2026
The ongoing debate about the association between benzodiazepines and dementiaDiego Legrand, Pasquale Roberge, Christian Bocti
Journal of the Neurological Sciences|January 21, 2026
The ongoing debate about the association between benzodiazepines and dementiaDiego Legrand, Pasquale Roberge, Christian Bocti
BMJ (Clinical Research Ed.)|November 28, 2012
Research paper most likely shows that benzodiazepines are used to treat early symptoms of dementiaChristian Bocti, Jessika Roy-Desruisseaux, Pasquale Roberge
General Hospital Psychiatry|March 18, 2014
Primary care practice characteristics associated with the quality of care received by patients with depression and comorbid chronic conditionsMatthew Menear, Arnaud Duhoux, Pasquale Roberge, et al.
Journal of Anxiety Disorders|August 28, 2009
A randomized, controlled clinical trial of standard, group and brief cognitive-behavioral therapy for panic disorder with agoraphobia: a two-year follow-upAndré Marchand, Pasquale Roberge, Sandra Primiano, et al.
Behavior Modification|April 9, 2008
Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysisPasquale Roberge, André Marchand, Daniel Reinharz, et al.
BMC Psychiatry|September 19, 2012
Quality of care for major depression and its determinants: a multilevel analysisArnaud Duhoux, Louise Fournier, Lise Gauvin, et al.
Plos One|November 14, 2024
Correction: Strategies to improve access to cognitive behavioral therapies for anxiety disorders: A scoping reviewJean-Daniel Carrier, Frances Gallagher, Alain Vanasse, et al.
Maturitas|March 30, 2013
Benzodiazepine and dementia: a time for reflectionChristian Bocti, Jessika Roy-Desruisseaux, Carol Hudon, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
The Psychiatric Clinics of North America|October 30, 2017
Transdiagnostic TherapyPeter J Norton, Pasquale Roberge
Journal of the Neurological Sciences|January 21, 2026
The ongoing debate about the association between benzodiazepines and dementiaDiego Legrand, Pasquale Roberge, Christian Bocti
Journal of the Neurological Sciences|January 21, 2026
The ongoing debate about the association between benzodiazepines and dementiaDiego Legrand, Pasquale Roberge, Christian Bocti
BMJ (Clinical Research Ed.)|November 28, 2012
Research paper most likely shows that benzodiazepines are used to treat early symptoms of dementiaChristian Bocti, Jessika Roy-Desruisseaux, Pasquale Roberge
General Hospital Psychiatry|March 18, 2014
Primary care practice characteristics associated with the quality of care received by patients with depression and comorbid chronic conditionsMatthew Menear, Arnaud Duhoux, Pasquale Roberge, et al.
Journal of Anxiety Disorders|August 28, 2009
A randomized, controlled clinical trial of standard, group and brief cognitive-behavioral therapy for panic disorder with agoraphobia: a two-year follow-upAndré Marchand, Pasquale Roberge, Sandra Primiano, et al.
Behavior Modification|April 9, 2008
Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysisPasquale Roberge, André Marchand, Daniel Reinharz, et al.
BMC Psychiatry|September 19, 2012
Quality of care for major depression and its determinants: a multilevel analysisArnaud Duhoux, Louise Fournier, Lise Gauvin, et al.
Plos One|November 14, 2024
Correction: Strategies to improve access to cognitive behavioral therapies for anxiety disorders: A scoping reviewJean-Daniel Carrier, Frances Gallagher, Alain Vanasse, et al.
Maturitas|March 30, 2013
Benzodiazepine and dementia: a time for reflectionChristian Bocti, Jessika Roy-Desruisseaux, Carol Hudon, et al.
Pageof 9